DLD Asset Management’s Eli Lilly LLY Stock Holding History

DLD Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$36.6M	Buy	+30,500	New	+$31.2M	2.42%	10

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DLD Asset Management's LLY Position: Q4 2025 in Review

DLD Asset Management sold out of Eli Lilly (LLY) in Q4 2025, closing a stake of 265 shares — an estimated $202K sold.

DLD Asset Management first reported a position in LLY in Q2 2025 and held it in 2 quarters. The position peaked at $1.65M in Q2 2025. 4,441 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

DLD Asset Management reported no remaining Eli Lilly position as of Q4 2025 after selling out during the quarter.
DLD Asset Management sold 265 Eli Lilly shares in Q4 2025, an estimated $202K.
DLD Asset Management first reported a position in Eli Lilly in Q2 2025 and held it in 2 quarters.
DLD Asset Management's Eli Lilly position peaked at $1.65M in Q2 2025.
4,441 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on DLD Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.